-
+44 +1
World's first "self-amplifying" vaccine approved in Japan
The approval of the world's first saRNA vaccine could signal a new era in how we prevent and treat everything from infections to cancer.
-
+26 +1
“Inverse vaccine” shows potential to treat multiple sclerosis and other autoimmune diseases
Pritzker Molecular Engineering researchers led by Prof. Jeffrey Hubbell showed that their compound can eliminate the autoimmune reaction associated with multiple sclerosis.
-
+27 +1
CDC recommends updated Covid vaccines for everyone ages 6 months and up, allowing shots to start within days
CDC Director Mandy Cohen still has to sign off on the panel's recommendation before the new Pfizer and Moderna Covid vaccines become available nationwide.
-
+19 +1
Did the COVID vax really alter people's periods?
COVID vaccines are not likely to blame for any major changes to the menstrual cycle, a new study shows.
-
+23 +1
‘Safe and effective’: first malaria vaccine to be rolled out in 12 African countries
A long-awaited vaccine for malaria has been announced for rollout across 12 African countries over the next two years, potentially saving tens of thousands of lives. An initial 18m doses of the world’s first malaria vaccine have been assigned to the countries where the risk of children falling ill and dying from malaria is highest, according to a statement from the global vaccine alliance Gavi, the World Health Organization (WHO) and Unicef.
-
+16 +1
Needle-free vaccine patches deliver jabs through the skin in seconds
With the onset of the Covid-19 pandemic, the world experienced an imminent crisis for which governments were largely unprepared. Despite vaccine breakthroughs within a year of the pandemic, the rollout of jabs was limited and lacked efficiency in the early stages.
-
+22 +1
FDA approves GSK's RSV vaccine for older adults, world's first shot against virus
The Food and Drug Administration on Wednesday approved an RSV vaccine produced by GlaxoSmithKline for use on adults ages 60 and older. The approval, the first ever globally by a regulatory body for an RSV vaccine, is a decisive victory for GSK in a race against drugmakers Pfizer and Moderna to bring to market a shot that targets the respiratory syncytial virus.
-
Analysis+16 +1
MIT’s Vaccine Printer: The Game-Changer in Vaccine Distribution
The printer generates vaccine-filled microneedle patches that can be stored long-term at room temperature and applied to the skin. Getting vaccines to people who need them isn’t always easy. Many vaccines require cold storage, making it difficult to ship them to remote areas that don’t have the n
-
+15 +1
Oral sex is now the leading risk factor for throat cancer
Oropharyngeal cancer has now become more common than cervical cancer in the US and the UK.
-
+4 +1
Moderna says it hopes to offer new vaccines for cancer, heart disease, and other conditions by 2030
Moderna's chief medical officer said advancements in mRNA technology since the outset of the Covid pandemic have ushered in a golden age for new vaccines.
-
+16 +1
Polio cases derived from new oral vaccine reported for first time
Experts have long understood that a new polio vaccine developed to try to minimize the risks associated with the oral polio vaccine made by Albert Sabin might also cause the problem it was created to sidestep. It’s now clear that theoretical risk is a real one.
-
+13 +1
Parents prone to black-and-white thinking are less likely to vaccinate their children against COVID-19
A study of parents of children aged 5-11 in Italy showed that black-and-white thinking was associated with the tendency to believe in conspiracies. This was in turn associated with a negative attitude towards vaccinating children against COVID-19. The study was published in Applied Cognitive Psychology. ...
-
+14 +1
Vaccine hesitancy is associated with interacting with low-quality information online, study finds
People who frequently interact with low-quality news websites tend to express more reservations about COVID-19 vaccines, according to new research that examined behavior on the social media platform Twitter. The findings have been published in the scientific journal PNAS Nexus.
-
+16 +1
A Chinese bank is offering customers a Pfizer COVID-19 vaccine if they deposit $500,000 into an account
A Hong Kong-based bank is offering new and existing customers an express reservation for a complimentary BioNTech/Pfizer mRNA vaccine if they deposit at least HK$4,000,000, or about $512,200, into an account. The vaccine is being offered as mainland China lifts its cross-border restrictions with Hong Kong and is among a number of "privileges" China CITIC Bank International, which is held by Chinese state-owned CITIC Group, is rolling out until March 31.
-
+4 +1
US approves world’s first vaccine for declining honey bees
The US has approved use of the world's first vaccine for honey bees. It was engineered to prevent fatalities from American foulbrood disease, a bacterial condition known to weaken colonies by attacking bee larvae. The US Department of Agriculture (USDA) approved a conditional license for the vaccine this week, according to the biotech firm behind its development.
-
+22 +1
BioNTech Delivers First Patient Dose In Herpes Vaccine Clinical Trial
BioNTech has finally dosed the first patient with its Herpes Vaccine (BNT163) in a candidate clinical trial. According to the German Vaccine maker, “The vaccine is designed to prevent genital lesions as part of a first-in-human Phase 1 clinical research study.”
-
+20 +1
Cancer mRNA vaccine completes pivotal trial
Researchers say they have successfully completed a trial of a personalised cancer vaccine that uses the same messenger-RNA technology as Covid jabs. The experimental vaccine, made by Moderna and MSD, is designed to prime the immune system to seek and destroy cancerous cells. Doctors hope work such as this could lead to revolutionary new ways to fight skin, bowel and other types of cancer.
-
+19 +1
Nearly 40 million children are dangerously susceptible as measles threat grows
Measles vaccination coverage has steadily declined since the beginning of the COVID-19 pandemic, according to a report published on Nov. 23 by the World Health Organization (WHO), the United States Centers for Disease Control and Prevention (CDC) and several university researchers, including Matthew Ferrari, director of the Center for Infectious Disease Dynamics at Penn State. Specifically, in 2021, a record high of nearly 40 million children missed a measles vaccine dose, with 25 million children missing their first dose and an additional 14.7 million children missing their second dose.
-
+20 +1
Misinformation About The CDC's Recommendation For Kids And COVID Vaccines Is Spreading Like Wildfire
When COVID-19 was filling emergency rooms, shuttering businesses, and turning parents and teachers into experts in Zoom, everyone hoped for a cure — or, if that wasn't possible, at least a way to avoid getting it. However, when a vaccine became available, many were wary of it. Rumors quickly spread about "the jab": It gives you cancer. It was approved before enough research could be done. It restructures your DNA. All these are false, according to Memorial Sloan-Kettering Cancer Center, but that hasn't stopped the rumor mill from grinding.
-
+12 +1
Vaccines to treat cancer possible by 2030, say BioNTech founders
Uğur Şahin and Özlem Türeci say mRNA Covid vaccine technology could be repurposed to help destroy cancer cells.
Submit a link
Start a discussion